Redmile Group, LLC
Top Portfolio Positions
35 positions ·
$1,984,563,976 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
18,133,242 | $891,430,176 | 44.92% | |
| KRYS |
Krystal Biotech, Inc.
Healthcare
|
673,505 | $173,979,811 | 8.77% | |
| STOK |
Stoke Therapeutics, Inc.
Healthcare
|
4,164,120 | $135,583,747 | 6.83% | |
| IMNM |
Immunome Inc.
Healthcare
|
5,558,885 | $121,572,814 | 6.13% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
7,732,808 | $119,858,524 | 6.04% | |
| ANNX |
Annexon, Inc.
Healthcare
|
14,549,768 | $80,605,714 | 4.06% | |
| ADCT |
ADC Therapeutics SA
Healthcare
|
15,470,502 | $58,014,382 | 2.92% | |
| RGNX |
REGENXBIO Inc.
Healthcare
|
4,368,804 | $36,610,577 | 1.84% | |
| STTK |
Shattuck Labs, Inc.
Healthcare
|
5,539,724 | $35,620,425 | 1.79% | |
| AGMB |
Agomab Therapeutics NV
Healthcare
|
2,892,176 | $30,338,925 | 1.53% |
Portfolio Trend
25 quarters · across all stocks
Holdings in KRYS
Shares Held
Position Value (USD)
25 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $173,979,811 | 673,505 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $167,081,390 | 677,705 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $116,754,823 | 661,388 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $91,200,723 | 663,471 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $133,002,802 | 737,675 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $117,992,395 | 753,175 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $147,488,897 | 810,245 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $187,510,763 | 1,021,078 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $268,362,922 | 1,508,250 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $215,019,427 | 1,733,189 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $232,390,572 | 2,003,367 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $301,326,001 | 2,566,661 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $153,177,196 | 1,913,280 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $150,252,216 | 1,896,645 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $132,398,286 | 1,899,545 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $124,658,464 | 1,898,545 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $120,816,544 | 1,815,698 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $127,371,815 | 1,820,898 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $103,502,774 | 1,982,432 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $140,904,976 | 2,072,132 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $158,712,569 | 2,060,132 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $100,502,160 | 1,675,036 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $64,658,732 | 1,501,945 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $58,391,637 | 1,409,745 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $45,479,832 | 1,051,800 | Shares | Sole | 2020-05-15 | |
| No 13F history on record for this holder in this stock. | ||||||